David Arkowitz Net Worth & Insider Trades
David Arkowitz - Chief Financial Officer, Flexion Therapeutics Inc
What is David Arkowitz's Net Worth?
The current estimated net worth of Flexion Therapeutics Inc's Chief Financial Officer, David Arkowitz, is estimated to be about $499.94K . David Arkowitz owns about 220,719 units of Flexion Therapeutics Inc common stock. In the last 3 years at Flexion Therapeutics Inc, David Arkowitz has sold an estimated value of $132.58K worth.
What is David Arkowitz's Past Insider Trading?
David Arkowitz's largest purchase order was 4,000 units , worth over $93.68K on August 10, 2018. David Arkowitz's largest sale order was 6,073 units , worth over $67.59K on January 7, 2021. In total, David Arkowitz has made about 17 transactions over 3 years of their time at Flexion Therapeutics Inc. David Arkowitz usually trades in May and June, with the busiest year in 2019. The most recent transaction was a sale order of 2,229 units , worth over $16.12K on May 12, 2021.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
David Arkowitz
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is David Arkowitz's' Mailing Address?
- Mailing address is C/o Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 MA
What are Flexion Therapeutics Inc's Past Insider Trades?
Flexion Therapeutics Inc's most recent insider trade came on July 20, 2021 by Christina Willwerth who sold 3,945 units worth $25.45K . In the last 7 years, insiders at Flexion Therapeutics Inc have sold an estimated value of $36.93M and bought an estimated value of $69.1M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Michael Clayman, President and CEO, Neil Bodick, Chief Scientific Officer, and Samuel Colella, Director .
Flexion Therapeutics Inc Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |